Market Executive Summary

Genotyping assays aim to discriminate between sequences, rather than measure the level of a particular DNA sequence.

Market Analysis and Insights: Global Genotyping Assay Market

The global Genotyping Assay market is projected to grow from US$ 26620 million in 2024 to US$ 76560 million by 2030, at a Compound Annual Growth Rate (CAGR) of 19.3% during the forecast period.

North America is expected to account for the largest market size in the global genotyping assay market during the forecast period, followed by the European region. Increasing adoption of technologically advanced genotyping products, high healthcare expenditure, advanced healthcare infrastructure, highly developed healthcare systems in the U.S. and Canada, numerous genotyping-based R&D projects, and a large number of leading genotyping Presence of manufacturers in the region, along with rising demand for genotyping products from pharmaceutical companies and rising investments by government agencies, are factors that account for a large share of the North America genotyping assay market.

Report Covers:

This report presents an overview of global market for Genotyping Assay market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030. 

This report researches the key producers of Genotyping Assay, also provides the revenue of main regions and countries.  of the upcoming market potential for Genotyping Assay, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Genotyping Assay revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Genotyping Assay market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Genotyping Assay revenue, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Global Genotyping Assay Companies Covered

Illumina, Thermo Fisher Scientific, Roche, Qiagen N.V., Agilent, Fluidigm, Genewiz, Integrated Dna Technologies, Perkinelmer, Bio-Rad Laboratories, Eurofins Scientific

Global Genotyping Assay Market, by Region

North America (U.S., Canada, Mexico)

Europe (Germany, France, UK, Italy, etc.)

Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

South America (Brazil, etc.)

Middle East and Africa (Turkey, GCC Countries, Africa, etc.)

Global Genotyping Assay Market, Segment by Type

PCR

Sequencing

Microarray

Others

Global Genotyping Assay Market, Segment by Application

Pharmacogenomics

Diagnostic Research

Animal Genetics

Agricultural Biotechnology

Others

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Revenue of Genotyping Assay in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Genotyping Assay companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.

Chapter 7: Europe by Type, by Application and by country, revenue for each segment.

Chapter 8: China by Type, and by Application, revenue for each segment.

Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.

Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.

Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Genotyping Assay revenue, gross margin, and recent development, etc.

Chapter 12: Analyst's Viewpoints/Conclusions.